← back to search

Masha G. Savelieff

Japan Center for Michigan Universities · US
Area of research
Physiology · Neurology
Research interest
Research interests include Amyotrophic Lateral Sclerosis Research, Alzheimer's disease research and treatments, Pain Mechanisms and Treatments, and Metal-Organic Frameworks: Synthesis and Applications.
h-index
36
citations
7,117
works
108
NIH funding
primary concept
Chemistry
email

Recent publications

The global and regional burden of diabetic peripheral neuropathy.
2025cited by 58position: contributordoi
Longitudinal Metabolomics in Amyotrophic Lateral Sclerosis Implicates Impaired Lipid Metabolism.
2025cited by 8position: contributordoi
Dietary Fatty Acid Composition Alters Gut Microbiome in Mice with Obesity-Induced Peripheral Neuropathy.
2025cited by 4position: contributordoi
Gene expression signatures from whole blood predict amyotrophic lateral sclerosis case status and survival.
2025cited by 1position: contributordoi
Dual targeting of Aurora Kinase A and poly (ADP-ribose) polymerase as a therapeutic option for patients with ovarian cancer: preclinical evaluations.
2025cited by 0position: contributordoi
Non-invasive in vivo measurements of metabolic alterations in the type 2 diabetic brain by <sup>1</sup>H magnetic resonance spectroscopy.
2024cited by 3position: contributordoi
New perspectives in diabetic neuropathy.
2023cited by 159position: contributordoi
The amyotrophic lateral sclerosis exposome: recent advances and future directions.
2023cited by 64position: contributordoi
Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles.
2023cited by 23position: contributordoi
Engineered extracellular matrices facilitate brain organoids from human pluripotent stem cells.
2023cited by 12position: contributordoi
Single-cell RNA sequencing identifies hippocampal microglial dysregulation in diet-induced obesity.
2023cited by 11position: contributordoi
Regional interneuron transcriptional changes reveal pathologic markers of disease progression in a mouse model of Alzheimer’s disease
2023cited by 0position: contributordoi
Human neural stem cells restore spatial memory in a transgenic Alzheimer’s disease mouse model by an immunomodulating mechanism
2023cited by 0position: contributordoi
Amyotrophic lateral sclerosis
The Lancet 2022cited by 990position: middledoi
Amyotrophic lateral sclerosis.
2022cited by 735position: contributordoi
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis
The Lancet Neurology 2022cited by 375position: middledoi
Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments.
2022cited by 244position: contributordoi
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes.
2022cited by 30position: contributordoi
Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status.
2022cited by 25position: contributordoi
Diabetes and dementia: Clinical perspective, innovation, knowledge gaps.
2022cited by 21position: contributordoi
Migrating Pyramidal Neurons Require DSCAM to Bypass the Border of the Developing Cortical Plate
Journal of Neuroscience 2022cited by 9position: middledoi
Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model.
2021cited by 34position: contributordoi
Immune-mediated vincristine-induced neuropathy: Unlocking therapies.
2021cited by 3position: contributordoi
Correction to "Bioinformatics Analysis of Metabolomics Data Unveils Association of Metabolic Signatures with Methylation in Breast Cancer".
2021cited by 0position: contributordoi
Untargeted metabolomics yields insight into ALS disease mechanisms.
2020cited by 70position: contributordoi
Differential Effects of Empagliflozin on Microvascular Complications in Murine Models of Type 1 and Type 2 Diabetes.
2020cited by 22position: contributordoi
Bioinformatics Analysis of Metabolomics Data Unveils Association of Metabolic Signatures with Methylation in Breast Cancer.
2020cited by 8position: contributordoi
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade.
2019cited by 377position: contributordoi
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response
Science Translational Medicine 2019cited by 290position: middledoi
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.
2019cited by 217position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Eva L. Feldman · Michigan State University25 papers (2019–2025) · 24 papers (2019–2025) · 21 papers (2019–2025)Stephen A. Goutman · Michigan United9 papers (2019–2025)Junguk Hur · SUNY Geneseo9 papers (2019–2025) · 6 papers (2020–2025)Kai Guo · China Southern Power Grid (China)6 papers (2019–2025)Faye E. Mendelson · University of Michigan4 papers (2021–2025)Mohamed Noureldein · University of Michigan–Ann Arbor4 papers (2023–2025)Lili Zhao · Children’s Hospital of Fudan University Xiamen Branch3 papers (2019–2025)Amy E. Rumora · Columbia University Irving Medical Center3 papers (2022–2025)Sarah E. Elzinga · University of Michigan3 papers (2021–2023)David L.H. Bennett · Oxford University Hospitals NHS Trust3 papers (2022–2025)Brian C. Callaghan · Japan Center for Michigan Universities3 papers (2022–2022)Samuel J. Teener · University of Michigan3 papers (2025–2025)Letizia Mazzini · John Wiley & Sons (United States)2 papers (2022–2022)Subramaniam Pennathur · University Medical Center2 papers (2020–2022)Melissa A. Elafros · University of Michigan2 papers (2022–2025)John M. Hayes · Heidelberg University2 papers (2023–2025) · 2 papers (2025–2025)